FDA gives COVID drug with Memphis ties fast-track to emergency use

By , Daily Memphian Updated: May 13, 2022 9:24 AM CT | Published: May 12, 2022 3:35 PM CT

The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.

Topics

sabizabulin Veru Inc Mitchell Steiner coronavirus COVID-19 GTx ARDS
Jane Roberts

Jane Roberts

Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.


Comments

Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here